Infection Prevention and Supply System Measures for COVID-19

「In these circumstances, our Group continued to make every effort to prevent infection for the safety of employees, their families, customers and patients, among others, while focusing on delivering COVID-19-related products such as vaccines, needles and syringes, and therapeutic drugs to help maintain the healthcare delivery system.」

「Regarding our response to COVID-19, we focused on delivering and supplying COVID-19-related products, including therapeutic drugs, vaccines, needles and syringes, and testing reagents and kits, to help prevent the spread of infection and maintain the healthcare delivery system. We also implemented infection-prevention measures throughout the company and conducted 3 workplace vaccination rounds for Group employees, their family members and others.」

「We conducted 2 vaccine doses for 7,400 employees, family members and others through workplace vaccinations, and are currently preparing to administer a third booster dose.」

「Regarding our response to COVID-19, we focused on delivering vaccines, needles and syringes, and therapeutic drugs in response to requests from government authorities. Of the workplace vaccinations that began on 21 June, 7,400 employees and family members had completed 2 doses by 1 September.」

「In response to requests from government authorities concerning COVID-19, we assisted with the delivery of vaccines, needles and syringes, among other items. We also conducted workplace vaccinations from 21 June for 5,000 employees, family members and others, and took measures to protect employee safety and prevent the spread of infection, including distributing surgical masks to all employees of our Group.」

「In these circumstances, as a group of companies engaged in healthcare, health and nursing care, our Group worked to give top priority to the stable supply of pharmaceuticals and other products in order to maintain the healthcare delivery system, under our social mission to ensure a stable supply of pharmaceuticals and other products even in emergencies.」

「We took measures to protect employee safety and prevent the spread of infection, including distributing surgical masks to all employees of our Group, including part-time and temporary employees, in quantities required for the first half of the fiscal year under review.」

「Under our Group's social mission to ensure a stable supply of pharmaceuticals and other products even in emergencies, we worked to give top priority to the stable supply of pharmaceuticals and other products in order to maintain the healthcare delivery system. We also took measures to protect employee safety and prevent the spread of infection, including distributing surgical masks to all employees of our Group, including part-time and temporary employees, in quantities required for the first half of the fiscal year under review.」

「We distributed surgical masks to all 13,960 employees of our Group, including part-time, temporary and outsourced personnel, in quantities equivalent to those required through early July, as part of our infection-prevention efforts. We also implemented telework and staggered start and finish times to reduce contact opportunities, and established a supply system by placing logistics and sales personnel on rotating shifts to help maintain the healthcare delivery system.」